Minerva Neurosciences Names Remy Luthringer as Executive Chairman and William Doyle as Lead Independent Director

World News: . []

WALTHAM Mass Feb 05 2018 GLOBE NEWSWIRE -- Minerva Neurosciences Inc NASDAQNERV a biopharmaceutical company focused on the development of therapies to treat central nervous system CNS disorders today announced that Dr Rmy Lu thringe...

More news and information about Minerva Neurosciences, Inc.

Published By:

Thomson Reuters: 13:30 GMT Monday 5th February 2018

Published: .

Search for other references to "minerva" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us